Trial Profile
A feasibility study of TS-1 schedule modification in elderly patients with metastatic and locally advanced pancreatic cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Adenosquamous carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 10 Mar 2012 New trial record